CVRx, Inc. (CVRX) vs Harvard Bioscience, Inc. (HBIO)
A side-by-side comparison of CVRx, Inc. and Harvard Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CVRX
CVRx, Inc.
$1.64HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
HBIO
Harvard Bioscience, Inc.
$8.67HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — CVRX vs HBIO
growth of $100 · dividends reinvested · last 5yCVRX -94.4% (-43.9%/yr)HBIO -88.4% (-35.0%/yr)HBIO compounded faster over this window
CVRX HBIO
CVRX vs HBIO: by the numbers
- •CVRX is the larger company ($43M vs $39M market cap).
- •Both run net losses; HBIO's is the smaller (-11.86% vs -84.93% net margin).
- •CVRX grew revenue faster over the past five years (46.51% vs -4.62% CAGR).
Metrics side by side
Valuation
| Metric | CVRX | HBIO |
|---|---|---|
| P/S ratio | 0.71 | 0.45 |
| P/B ratio | 2.17 | 5.27 |
| EV / EBITDA | N/A | 10.61 |
Profitability
| Metric | CVRX | HBIO |
|---|---|---|
| Gross margin | 86.60% | 58.16% |
| Operating margin | -90.49% | 1.17% |
| Net margin | -84.93% | -11.86% |
| ROE | -260.45% | -140.36% |
| ROIC | -59.93% | 1.99% |
Growth (annualized)
| Metric | CVRX | HBIO |
|---|---|---|
| Revenue CAGR (5Y) | 46.51% | -4.62% |
| Total return CAGR (5Y) | -37.86% | -34.33% |
Frequently asked
- Which has grown faster, CVRX or HBIO?
- Over the past five years, CVRX grew revenue faster — CVRX at a 46.51% CAGR versus HBIO at -4.62%.
- How have CVRX and HBIO total returns compared?
- Over the past 5 years, CVRX delivered -37.86% and HBIO delivered -34.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CVRx ROEHarvard Bioscience ROECVRx operating marginHarvard Bioscience operating marginCVRx revenue growthHarvard Bioscience revenue growthCVRx free cash flowHarvard Bioscience free cash flow
CVRx & Harvard Bioscience appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.